Understanding sexual health and prevention among women in Alabama
CAMELLIA Cohort: A longitudinal study to understand sexual health and prevention among women in Alabama
This study is looking at how alcohol use affects sexual health and HIV risk among women in Alabama, including both cisgender and transgender individuals, to help find better ways to prevent HIV and improve access to treatments like PrEP.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11094574 on NIH RePORTER |
What this research studies
This research investigates the sexual health and HIV prevention strategies among women in Alabama, particularly focusing on the impact of alcohol use on sexual behavior and HIV risk. The study involves a cohort of 800 women, including cis- and trans-gender individuals, who are at significant risk for HIV based on recent sexually transmitted infections. By analyzing both subjective and objective measures of alcohol consumption, the research aims to identify factors that contribute to HIV risk and improve access to preventive measures like PrEP.
Who could benefit from this research
Good fit: Ideal candidates for this research are women, including cis- and trans-gender individuals, living in Alabama who are at risk for HIV due to recent sexually transmitted infections.
Not a fit: Patients who do not reside in Alabama or who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV prevention strategies tailored for women in Alabama, particularly those from communities of color.
How similar studies have performed: Previous research has shown success in understanding HIV prevention strategies in similar populations, indicating that this approach is both relevant and necessary.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Elopre, Latesha Ellen — University of Alabama at Birmingham
- Study coordinator: Elopre, Latesha Ellen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.